Michael Artinger
Amministratore Delegato presso Neurexis Therapeutics, Inc.
Profilo
Michael A.
Artinger is currently the Chief Executive Officer & Director at Neurexis Therapeutics, Inc. and Solaris Vaccines, Inc. He is also the Chairman at Zebra Analytix, Inc. and the Executive Chairman at Cellia Science, Inc. Additionally, he holds the position of Executive VP & Managing Director at VIC Technology Venture Development LLC.
In his former positions, Dr. Artinger served as the President & Chief Executive Officer at Nanodisc, Inc. He also worked as the Director of Business Development at The Boston Consulting Group, Inc. and as the Director of Technology Assessment at Decision Resources, Inc. Furthermore, he held the role of Senior Scientist & Program Leader at Oscient Pharmaceuticals Corp.
and Vice President of Marketing & Strategic Partnering at ViroCyt, Inc. He also served as the Vice President of Commercial Development at InDevR, Inc.Dr. Artinger obtained his undergraduate and doctorate degrees from the University of California, Irvine.
Posizioni attive di Michael Artinger
| Società | Posizione | Inizio |
|---|---|---|
Neurexis Therapeutics, Inc.
 Neurexis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neurexis Therapeutics, Inc. provides healthcare services. The company is headquartered in Aurora, CO. | Amministratore Delegato | - |
VIC Technology Venture Development LLC
 VIC Technology Venture Development LLC Investment ManagersFinance VIC Technology Venture Development LLC (VIC Technology) is a venture capital firm founded in 2000 by Calvin R. Goforth. The firm is headquartered in Fayetteville, Arkansas. | Investitore di Private Equity | 01/01/2018 |
Zebra Analytix, Inc.
 Zebra Analytix, Inc. Industrial MachineryProducer Manufacturing Zebra Analytix, Inc. develops miniature gas chromatography systems. It specializes in column refurbishment, micro pre-concentrators and custom designs for research. The company is headquartered in Fayetteville, AR. | Presidente | 01/01/2021 |
Cellia Science, Inc.
 Cellia Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cellia Science, Inc. develops and commercializes blood cell analyzers that provide rapid, actionable blood cell counts at the point of care. The company was founded in 2021 and is based in Fayetteville, AR. Cellia Science's lead device provides neutrophil and platelet counts for chemotherapy patients at risk of neutropenia and thrombocytopenia, using label-free deep-UV imaging technology exclusively licensed from a third party. The technology will be applied to additional diseases with significant unmet need in the future. Kelly Mabry has been the CEO of the company since 2022. | Presidente | 01/01/2022 |
| Solaris Vaccines, Inc. | Amministratore Delegato | 01/08/2021 |
Precedenti posizioni note di Michael Artinger
| Società | Posizione | Fine |
|---|---|---|
InDevR, Inc.
 InDevR, Inc. Medical SpecialtiesHealth Technology InDevR, Inc. develops and delivers analytical tools for detection and characterization of biological molecules and microorganisms. The firm offers on the ampliPHOX Colorimetric Detection platform and Custom Arrays to enable its customers a low risk means to explore the high utility of focused microarrays. The company was founded by Kathy L. Rowlen, Laura Kuck and John W. Birks in 2003 and is headquartered in Boulder, CO. | Corporate Officer/Principal | - |
ViroCyt, Inc.
 ViroCyt, Inc. Miscellaneous Commercial ServicesCommercial Services ViroCyt, Inc. develops life science instrumentation and assays products for the analysis of viruses and microorganisms. The company was founded in 2012 and is headquartered in Broomfield, CO. | Vendite & Marketing | - |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Decision Resources, Inc.
 Decision Resources, Inc. Investment ManagersFinance Decision Resources, Inc. provides information, analysis, and insight on critical issues to the healthcare industry worldwide. It provides market research publications, advisory and consulting services for pharmaceutical companies, managed care organizations, and medical device manufacturers. The company was founded in 1990 and is headquartered in Burlington, MA. | Presidente | 18/01/2013 |
| ░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Michael Artinger
| University of California, Irvine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Nanodisc, Inc.
 Nanodisc, Inc. Medical/Nursing ServicesHealth Services Nanodisc, Inc. provides drug research services. It provides services to pharmaceutical researchers and developers. The company was founded by Stephen G. Sligar and Harry F. Arader on November 12, 2003 and is headquartered in Urbana, IL. | Health Services |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
Decision Resources, Inc.
Decision Resources, Inc. Investment ManagersFinance Decision Resources, Inc. provides information, analysis, and insight on critical issues to the healthcare industry worldwide. It provides market research publications, advisory and consulting services for pharmaceutical companies, managed care organizations, and medical device manufacturers. The company was founded in 1990 and is headquartered in Burlington, MA. | Finance |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
ViroCyt, Inc.
ViroCyt, Inc. Miscellaneous Commercial ServicesCommercial Services ViroCyt, Inc. develops life science instrumentation and assays products for the analysis of viruses and microorganisms. The company was founded in 2012 and is headquartered in Broomfield, CO. | Commercial Services |
InDevR, Inc.
InDevR, Inc. Medical SpecialtiesHealth Technology InDevR, Inc. develops and delivers analytical tools for detection and characterization of biological molecules and microorganisms. The firm offers on the ampliPHOX Colorimetric Detection platform and Custom Arrays to enable its customers a low risk means to explore the high utility of focused microarrays. The company was founded by Kathy L. Rowlen, Laura Kuck and John W. Birks in 2003 and is headquartered in Boulder, CO. | Health Technology |
Neurexis Therapeutics, Inc.
Neurexis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neurexis Therapeutics, Inc. provides healthcare services. The company is headquartered in Aurora, CO. | Health Technology |
VIC Technology Venture Development LLC
VIC Technology Venture Development LLC Investment ManagersFinance VIC Technology Venture Development LLC (VIC Technology) is a venture capital firm founded in 2000 by Calvin R. Goforth. The firm is headquartered in Fayetteville, Arkansas. | Finance |
Zebra Analytix, Inc.
Zebra Analytix, Inc. Industrial MachineryProducer Manufacturing Zebra Analytix, Inc. develops miniature gas chromatography systems. It specializes in column refurbishment, micro pre-concentrators and custom designs for research. The company is headquartered in Fayetteville, AR. | Producer Manufacturing |
Cellia Science, Inc.
Cellia Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cellia Science, Inc. develops and commercializes blood cell analyzers that provide rapid, actionable blood cell counts at the point of care. The company was founded in 2021 and is based in Fayetteville, AR. Cellia Science's lead device provides neutrophil and platelet counts for chemotherapy patients at risk of neutropenia and thrombocytopenia, using label-free deep-UV imaging technology exclusively licensed from a third party. The technology will be applied to additional diseases with significant unmet need in the future. Kelly Mabry has been the CEO of the company since 2022. | Commercial Services |
| Solaris Vaccines, Inc. |
- Borsa valori
- Insiders
- Michael Artinger
